Xenon Pharmaceuticals Inc. (XENE)
Nasdaq: XENE · Pharmaceutical Preparations · filing with the SEC since 2013
The company now
Xenon Pharmaceuticals Inc. is classed by the SEC under Pharmaceutical Preparations (industry code 2834). In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $7.5 million and a loss of $346 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.